SBIR/STTR Research Award
DEVELOPMENT OF AN ULTRASENSITIVE, RAPID AND EASY-TO USE AT-HOME MOLECULAR TEST FOR HCV, HBV AND HIV
Award amount
$299,961Program and phase
SBIR · Phase IAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CUBIT DIAGNOSTICS, INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- MX5XL9PAEUB9
- Solicitation number
- PHS-2024-1
- Topic code
- 127
Research abstract
Multiplexed Patient Administered Diagnostics for Hepatitis B, Hepatitis C, and HIV: HIV and viral hepatitis infections share common modes of transmission and social and structural barriers to accessing care and services among key populations. Coinfection with HIV significantly impacts the pathogenesis of HBV and HCV and is associated with reduced spontaneous clearance of HCV and HBsAg, higher rates of chronicity and occult HBV, higher HCV viral loads, rapid disease progression, and increased risk of morbidity and mortality due to cirrhosis and HCC. Integrated strategies for screening and diagnosis of HIV and viral hepatitis infections are therefore critical to an effective global health response. This contract aims to develop a nucleic acid amplification test for detection of HIV and HBV from whole capillary blood using the Cubit platform.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A SIMPLE MULTIPLEXED PLATFORM FOR SELF-ADMINISTERED HIV AND HEPATITIS B TESTING
- AN EASY-TO-USE, LOW-COST TRIPLEX RDT FOR THE SIMULTANEOUS DIAGNOSIS OF HBV, HCV, AND HIV INFECTION, COMPATIBLE WITH FIELD USE IN LMICS AND AT-HOME USE IN THE US